Patrick Campbell > J A Kemp > London, England > Lawyer Profile

J A Kemp
80 Turnmill Street
London
EC1M 5QU
England

Work Department

Biotechnology and Life Sciences

Position

Partner, European and UK Patent Attorney

Career

Pat is a European and UK Patent Attorney and Head of the Biotechnology and Life Sciences Group, one of the biggest Groups of its type in Europe.

Pat has a life sciences and pharmaceuticals practice for clients based in the United States, the UK, the rest of Europe and Japan. He has directed prosecution of patent families covering over 70 countries, but a high proportion of Pat’s work is prosecution, opposition and appeal work in the European Patent Office (EPO). He has handled about 80 opposition matters in the EPO over the course of his career to date. He has advised on multi-national litigation and counsels clients on freedom-to-operate issues.

Examples of subjects on which Pat has helped clients include the following: rozanolixizumab, an antibody for treating autoimmune diseases; bimekizumab, an antibody for treating psoriasis; romosozumab, an antibody for treating osteoporosis; a platform technology for delivering proteins to the brain for treating neurodegenerative and metabolic diseases; gene editing and gene therapy technologies; a platform technology for oral delivery of vaccines; acellular whooping cough vaccines; manufacturing processes for antibodies and other biological molecules; biologicals including pegylated G-CSF, a product used to treat patients suffering from low levels of white blood cells as a result of cancer chemotherapy; small molecule drugs including enzalutamide, an important drug for prostate cancer; techniques for converting non-pluripotent cells into pluripotent cells; methods of engineering bacteria to produce chemicals for making polymers; drought-resistant plants; and diagnostic tests for heart disease and cancer.

Pat was a scholar at Cambridge University and graduated from there in 1991 with a first class degree in Natural Sciences and specialisms in biochemistry and organic chemistry. He qualified as a European patent attorney in 1995 and as a UK chartered patent attorney in 1996. During his professional exams, he was awarded the prize for the top mark in the UK in the Patent Attorneys’ Practice Paper.

Pat joined J A Kemp in 1991 and became a partner in 2001.

Memberships

Fellow of the Chartered Institute of Patent Attorneys (CIPA); Member of the Institute of Professional Representatives before the European Patent Office (EPI)

Education

University of Cambridge, Masters Degree in Natural Sciences

Lawyer Rankings

London > TMT (technology, media and telecoms) > PATMA: Patent attorneys

J A Kemp is well placed to advise clients on the entire gamut of patent-related mandates, from drafting and filings, to prosecutions, oppositions, and appeals before the EPO, freedom to operate mandates, and portfolio management, with offices located in London, Oxford, Cambridge, Paris, and Munich. Start-ups and growing businesses, in addition to large corporations and prestigious academic institutions, form the group’s impressive client base, with a geographical spread across the UK, Europe, the US, and Japan. The firm is also increasingly active before the UPC. Senior partner Martin Jackson leads the engineering and IT group, having taken over from Nigel Price following his retirement. Oxford-based Amanda Simons spearheads the chemistry and pharmaceuticals department, and Patrick Campbell heads up the firm’s biotechnology and life sciences practice. Mark Roberts sits at the helm of the medical devices group, while Ravi Srinivasan chairs the pharmaceuticals team and John Leeming steers the software group. Graham Lewis is also of note for his role as head of the Supplementary Protection Certificates group. In team news, the ‘superbly intelligent patent litigator‘ John Hornby joined the firm from Lewis Silkin in March 2024.